IP Library Granted Patent US 11,845,846
Granted Patent B2
US 11,845,846 · App. 16/642,205 · Granted Dec 19, 2023

Formulation for 3D printing and a 3D printed article

Inventors: Kevin Jeremiah O'Sullivan (Limerick, IE); Leonard William O'Sullivan (Limerick, IE); Seamus Clifford (Limerick, IE); Alice Shannon (Limerick, IE)
Assignee: UNIVERSITY OF LIMERICK
C08K3/22A61B6/583A61L31/028A61L31/18B29C64/106B33Y10/00B33Y70/10B33Y80/00B29K2509/02B29K2995/0011B29L2031/753C08K2003/2244C08K2003/2286C08K2201/003C08K2201/011
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,845,846
App. No.
16/642,205
Granted
Dec 19, 2023
Kind
B2
Abstract

A flowable liquid formulation for 3D printing is described. The formulation comprises from 0.1 to 25 wt. % radiopaque particles, wherein at least 50% by weight of the particles have a diameter of at most 100 nm. The formulation further comprises monomeric, oligomeric and/or polymeric precursors adapted for polymerization to form a solidified article. Also described is an article ( 100 ) formed by 3D printing, the article ( 100 ) comprising a first 3D printed region ( 110 ) having a first radiopacity and a second 3D printed region ( 120 ) having a second radiopacity, wherein the first radiopacity is greater than the second radiopacity. Also described is a method of forming the article ( 100 ).

Claims (13)

1. A flowable liquid formulation for 3D printing a solidified article having a radiopacity of at least 200 HU up to 1200 HU, the flowable liquid formulation comprising:

from 0.1 to 25 wt. % radiopaque particles, wherein at least 50% of the particles have a diameter of at most 100 nm; and

monomeric, oligomeric and/or polymeric precursors adapted for polymerization to form the solidified article;

wherein the flowable liquid formulation comprises from 5 to 80 wt. % oligomeric precursors; and

wherein the dynamic viscosity, measured at 20° C., of the flowable liquid formulation is in a range from 100 to 1000 centipoise.

2. The flowable liquid formulation according to claim 1 comprising from 5 to 10 wt. % radiopaque particle.

3. The flowable liquid formulation according to claim 1 wherein the radiopaque particles comprise ZrO 2 particles, Nb 2 O 5 particles, Ta 2 O 5 particles and/or silver acetate (CH 3 CO 2 Ag) particles.

4. The flowable liquid formulation according to claim 1 comprising from 40 to 80 wt. % monomeric, oligomeric and/or polymeric precursors.

5. The flowable liquid formulation according to claim 1 comprising from 20 to 60 wt. % monomeric precursors.

6. The flowable liquid formulation according to claim 1 comprising at least one of a photoinitiator, a retarder solvent, a filler and a colouring agent.

7. An article formed by 3D printing, the article having a radiopacity of at least 200 HU up to 1200 HU, the article comprising a first 3D printed region having a first radiopacity and a second 3D printed region having a second radiopacity, wherein the first radiopacity is greater than the second radiopacity, wherein the first 3D printed region is obtained by polymerisation of the formulation according to claim 1 .

8. The article according to claim 7 , wherein the artic a calibration standard for a medical radiography apparatus.

9. The article according to claim 7 , wherein the article is a medical device.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 26, 2020
From: O'SULLIVAN, KEVIN JEREMIAH; O'SULLIVAN, LEONARD WILLIAM; CLIFFORD, SEAMUS; SHANNON, ALICE
To: UNIVERSITY OF LIMERICK
Reel/Frame 051939/0399 →
Priority Claims (1)
GB 1714169 · Sep 4, 2017 · national
Continuity (1)
Related Publication 20200354542A1 · Nov 12, 2020